Laura Argíz

ORCID: 0000-0003-0703-3756
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Food Allergy and Anaphylaxis Research
  • Eosinophilic Esophagitis
  • Allergic Rhinitis and Sensitization
  • Drug-Induced Adverse Reactions
  • Autoimmune Bullous Skin Diseases
  • Urticaria and Related Conditions
  • Occupational exposure and asthma
  • Contact Dermatitis and Allergies
  • Child Nutrition and Feeding Issues
  • Viral gastroenteritis research and epidemiology
  • Immunodeficiency and Autoimmune Disorders
  • Lanthanide and Transition Metal Complexes
  • Healthcare and Venom Research
  • Food Safety and Hygiene
  • Insect and Pesticide Research
  • Asthma and respiratory diseases
  • Infant Nutrition and Health
  • Acute Kidney Injury Research
  • Identification and Quantification in Food
  • Respiratory and Cough-Related Research

Clinica Universidad de Navarra
2019-2024

Hospital Universitario de La Princesa
2016-2020

10.1016/j.jaip.2018.10.030 article EN The Journal of Allergy and Clinical Immunology In Practice 2018-11-29

Background Oral food challenge (OFC) is the gold standard for diagnosis of acute Food Protein-Induced Enterocolitis Syndrome (FPIES). No diagnostic/prognostic biomarkers are available, and OFC assessment criteria not validated. Objective. To assess clinical-haematological changes predictors severity FPIES reactions at OFC. Methods Observational multicentre prospective study. Children aged 0-18 years diagnosed with were recruited follow-up in 12 tertiary centres Spain Italy. Outcomes (as...

10.1016/j.jaip.2024.05.024 article EN cc-by-nc-nd The Journal of Allergy and Clinical Immunology In Practice 2024-05-23

ABSTRACT Background Food protein‐induced enterocolitis syndrome (FPIES) is a food allergy primarily affecting infants, often leading to vomiting and shock. Due its poorly understood pathophysiology lack of specific biomarkers, diagnosis frequently delayed. Understanding FPIES genetics can shed light on disease susceptibility pathophysiology—key developing diagnostic, prognostic, preventive therapeutic strategies. Using well‐characterised cohort patients we explored the potential genome‐wide...

10.1111/cea.14564 article EN cc-by-nc-nd Clinical & Experimental Allergy 2024-09-30

10.26226/morressier.5acc8ad0d462b8028d89acd0 preprint EN 2018-05-25

10.18176/jiaci.0412 article EN Journal of Investigational Allergology and Clinical Immunology 2019-05-07

10.26226/morressier.5acc8ad4d462b8028d89b6df preprint EN 2018-05-25

10.26226/morressier.5afac509d0241f0023cc9ceb preprint EN 2018-05-25
Coming Soon ...